KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
<h4>Introduction</h4>Oncogenic mutation within the KRAS gene represents a negative predictor for treatment response to anti-epidermal growth factor receptor (EGFR) in patients with colorectal cancer. Recently, we have shown no relevant heterogeneity for KRAS mutation status within and between pre- a...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Public Library of Science (PLoS)
2020-01-01
|
| Seria: | PLoS ONE |
| Dostęp online: | https://doi.org/10.1371/journal.pone.0239806 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|